Explore the words cloud of the PREMADES project. It provides you a very rough idea of what is the project "PREMADES" about.
The following table provides information about the project.
Coordinator |
KUARTISMED MEDIKAL ARASTIRMA GELISTIRME DANISMANLIK EGITIM SANAYI VE TICARET LIMITED SIRKETI
Organization address contact info |
Coordinator Country | Turkey [TR] |
Project website | http://www.kuartismed.com |
Total cost | 2˙081˙250 € |
EC max contribution | 1˙456˙875 € (70%) |
Programme |
1. H2020-EU.3.6. (SOCIETAL CHALLENGES - Europe In A Changing World - Inclusive, Innovative And Reflective Societies) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) |
Code Call | H2020-SMEINST-2-2016-2017 |
Funding Scheme | SME-2 |
Starting year | 2017 |
Duration (year-month-day) | from 2017-03-01 to 2020-01-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | KUARTISMED MEDIKAL ARASTIRMA GELISTIRME DANISMANLIK EGITIM SANAYI VE TICARET LIMITED SIRKETI | TR (CANKAYA ANKARA) | coordinator | 1˙456˙875.00 |
PREMADES is a medical diagnostic device, developed to provide health care practitioners an objective yet noninvasive means for the assessment of feeding maturity, by analyzing the swallowing patterns acquired using sensors placed around their hyoid regions. It is also intended to monitor the improvements by regular measurements and analysis of feeding maturity in the preterm infants and compare past evaluations. This non-invasive design will be painless for infants and user friendly for the medical staff. Currently, in practice, doctors utilize observational, trial-and-error techniques or nursing assessment for identification of feeding skills in preterm infants, which are mostly subjective. Efforts aimed at more objective assessment techniques have focused on invasive, pressure measurement methods that can be particularly painful for infants. However, such methods are not well suited for regular and real-time monitoring of feeding maturity, thus are not preferred in practice. As a H2020 SME Phase-1 beneficiary, an intensive feasibility study, including market, profitability analyses, possible improvements required for the prototype and a work plan has been successfully prepared. PREMADES, will meet a highly important need, particularly in the neonatal medicine. The product is expected to be proper for point of care usage, marketable globally. Total available market size of our product is €716M/year. According to the results of our detailed financial feasibility study, we are planning to achieve €67M revenue creating a total of 65 new jobs at the end of the fourth year. In Phase-2, further technical improvements will be made on the prototype and intensive commercialization activities will be implemented. To ensure a successful entrance and fast penetration into the European markets, the outcomes of the Phase 1 studies will be carefully used in Phase 2, which will help in terms of the design, production and marketing procedures to be conducted in a right manner.
Project website | Websites, patent fillings, videos etc. | 2019-11-06 11:46:50 |
Take a look to the deliverables list in detail: detailed list of PREMADES deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREMADES" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PREMADES" are provided by the European Opendata Portal: CORDIS opendata.